Search Results - Ryon P Graf

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Authors response to “Letter to the Editor”: “Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types” by David R Gandara, Ryon P Graf

    Published in Journal for ImmunoTherapy of Cancer (2025-07-01)
    Get full text
    Article


  2. 2

    Comparison of PD-L1 tumor cell expression with 22C3, 28-8, and SP142 IHC assays across multiple tumor types by Jeffrey S Ross, Richard S P Huang, Jake G Maule, Lani K Clinton, Ryon P Graf, Jinpeng Xiao, Geoffrey R Oxnard

    Published in Journal for ImmunoTherapy of Cancer (2022-10-01)
    Get full text
    Article


  3. 3

    Clinical and Genomic Factors Associated with Greater Tumor Mutational Burden in Prostate Cancer by Helen Y. Hougen, Ryon P. Graf, Gerald Li, Julia C.F. Quintanilha, Douglas I. Lin, Jeffrey S. Ross, Sanoj Punnen, Brandon A. Mahal

    Published in European Urology Open Science (2023-09-01)
    Get full text
    Article


  4. 4

    Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis by David P Carbone, David Spigel, Jeffrey S Ross, Karthikeyan Murugesan, Gerald Li, Richard S P Huang, Ryon P Graf, Geoffrey R Oxnard, Alexa Schrock, Liangliang Zhang, Khaled Tolba, Jacob Sands

    Published in Journal for ImmunoTherapy of Cancer (2023-01-01)
    Get full text
    Article


  5. 5

    Pan-tumor validation of a NGS fraction-based MSI analysis as a predictor of response to Pembrolizumab by Douglas I. Lin, Julia C. F. Quintanilha, Natalie Danziger, Lixin Lang, Diane Levitan, Cynthia Hayne, Matthew C. Hiemenz, David L. Smith, Lee A. Albacker, Jeffrey Leibowitz, Douglas A. Mata, Brennan Decker, Sotirios Lakis, Nimesh R. Patel, Ryon P. Graf, Julia A. Elvin, Jeffrey S. Ross, Varun Pattani, Richard S. P. Huang, Amy K. Wehn

    Published in npj Precision Oncology (2024-09-01)
    Get full text
    Article


  6. 6

    Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types by Vivek Subbiah, Samuel J Klempner, Neeraj Agarwal, David P Carbone, Amit Mahipal, Shilpa Gupta, David Fabrizio, Jeffrey S Ross, Gerald Li, David R Gandara, Miles C Andrews, Jonathan W Riess, Ramez N Eskander, Ryon P Graf, Geoffrey R Oxnard, Sarah Sammons, Jeremy Snider, Lilia Bouzit, Cheryl Cho-Phan, Megan Price, Julia C F Quintanilha, Richard Sheng Poe Huang

    Published in Journal for ImmunoTherapy of Cancer (2025-02-01)
    Get full text
    Article


Search Tools: